Back

Learner’s Digest International (TM)

  • Head and Neck Neoplasms
  • Immunotherapy

Evolving Role of Immunotherapy in Head and Neck Cancers

The goal of this program is to improve management of head and neck cancer using immunotherapy. After hearing and assimilating this program, the clinician will be better able to:Assess eligibility for immunotherapy in patients with head and neck cancer.Integrate immunotherapy into multidisciplinary care plans, including surgery or radiation, for head and neck cancer.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

ABOHNS — Self-AssessmentUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Membership pricing — $1,095 / year

This provider prices CME through membership. Individual courses may also be sold separately.

See plans on audio-digest.org

Listed by the provider

  • Enduring / On-demand
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Membership pricing
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Nov 2, 2028 2 years left